2nd Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Waste (hazardous/solid/interstate/nuclear) WAS

Communication with EPA regarding health care industry study on practices related to disposal of unused pharmaceuticals.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); White House Office; SENATE; Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA)

Health Issues HCR

FDA Appropriations FY10. Communication to White House Office on Health Care Reform. Support for HR 2891, Access to Frontline Health Care Act of 2009, all provisions. Support for S 245, Retooling the Healthcare Workforce for an Aging America Act of 2009. Letter urging funding for residency programs in America's Affordable Health Choices Act, HR 3200. Statement to Senate Finance Committee on Healthcare Reform Delivery Options and Coverage Options. Statement to Senate Finance Committee on workforce. Statement to House Energy and Commece Committee on Health Reform. Letters to Senate Finance and Ways and Means Committees on residency funding. Communication with Congressional Budget Office on heatlh care reform. Communication with FDA regarding market withdrawal of morphine sulphate oral solution. Communicatin with FDA on Risk Evaluation and Mititgation Strategies for certain opioid drugs. Communication with NIOSH regarding additions and deltions to hazardous drug list. Communication with FDA regarding safety of acetaminophen-containing drug products.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; White House Office; Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2891 (111th), H.R. 3200 (111th)

Medicare/Medicaid MMM

Communication with CMS on Hospital Inpatient Prospective Payment System. Communication with Office of the National Coordinator on Health Information Technology regarding definition of "meaningful use."

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Environmental Protection Agency (EPA); Drug Enforcement Administration (DEA); Health Resources & Services Administration (HRSA); White House Office; HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC)

Pharmacy PHA

Communication with FDA and HHS regarding standards for securing the drug supply chain and the National Drug Code system. Communication with the Office of the National Coordinator regarding "Draft Use of Electronic Health Records in Clinical Research. Communication with Food and Drug Administration on evaluation of consumer medication information. Communication with Health Resources and Services Administration on National Quality Forum priorities and pharmacist residency training and workforce issues. Comments to Office of the National Coordinator regarding health information technology extension program. Communication with Drug Enforcement Administration regarding implementation of Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Communication with Centers for Medicare and Medicaid Services regarding anticoagulation clinic billing issue.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.